Page results
-
The British Medical Association (BMA) has announced that its junior doctor members will take industrial action between 11 and 15 April. The strike action will impact all UCLH hospitals.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
Information about energy conservation for UCLH patients with mitochondrial disease.
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
-
Information for patients having VATS/Thoracotomy procedure.
-
UCLH has developed a post-Covid-19 service to help survivors of the virus with their long-term recovery.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
UCLH is a specialist centre for the diagnosis and treatment of gastric (stomach) cancer for the people of north and east London and west Essex.
-
This page describes a surgical keyhole procedure to remove fibroids, called a laparoscopic myomectomy.
File results
-
FOI/2024/0481 - Maternity unit closed to new admissions 2018-2023
-
FOI/2023/0462 - Patients to hotels
-
FOI/2023/0515 - Visitor policy in response to Covid-19
-
FOI/2023/0457 - Psychiatric/ behavioural problems linked to psychiatric disorders use of force policies
-
FOI/2023/0525 - Senior doctors/ consultants/ junior doctors pay
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2024/0236 - Proton Beam Therapy Centre
-
FOI/2023/0568 - Adverse reactions to the Astra Zeneca Covid vaccine
-
FOI/2023/0603 - Treatment of dermatological conditions
-
FOI/2023/0670 - Treatment with immunomodulatory medications